Predicting Cognitive Decline in Older Adults by Baerresen, Kimberly M.
Loma Linda University
TheScholarsRepository@LLU: Digital Archive of Research,
Scholarship & Creative Works
Loma Linda University Electronic Theses, Dissertations & Projects
9-2014
Predicting Cognitive Decline in Older Adults
Kimberly M. Baerresen
Follow this and additional works at: http://scholarsrepository.llu.edu/etd
Part of the Clinical Psychology Commons
This Dissertation is brought to you for free and open access by TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative
Works. It has been accepted for inclusion in Loma Linda University Electronic Theses, Dissertations & Projects by an authorized administrator of
TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative Works. For more information, please contact
scholarsrepository@llu.edu.
Recommended Citation
Baerresen, Kimberly M., "Predicting Cognitive Decline in Older Adults" (2014). Loma Linda University Electronic Theses, Dissertations
& Projects. 180.
http://scholarsrepository.llu.edu/etd/180
  
 
 
LOMA LINDA UNIVERSITY 
School of Behavioral Health 
in conjunction with the 
Faculty of Graduate Studies 
 
 
 
____________________ 
 
 
 
 
Predicting Cognitive Decline in Older Adults 
 
 
by: 
 
 
Kimberly M. Baerresen 
 
 
 
____________________ 
 
 
 
 
A Dissertation submitted in partial satisfaction of 
the requirements for the degree of 
Doctor of Philosophy in Clinical Psychology 
 
 
 
____________________ 
 
 
 
 
September 2014 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2014 
 
Kimberly M. Baerresen 
All Rights Reserved
iii 
Each person whose signature appears below certifies that this dissertation in his/her 
opinion is adequate, in scope and quality, as a dissertation for the degree Doctor of 
Philosophy. 
 
 
 
 
 
 
 , Chairperson 
David A. Vermeersch, Professor of Psychology  
 
 
 
 
 , Co chairperson 
Karen J. Miller, Associate Clinical Professor of Psychiatry and Biobehavioral Sciences, 
David Geffen School of Medicine, UCLA, Semel Institute for Neuroscience and Human 
Behavior 
 
 
 
 
  
Richelin V. Dye, Health Sciences Clinical Instructor of Psychiatry and Biobehavioral 
Sciences Division of Geriatric Psychiatry, David Geffen School of Medicine at UCLA 
 
 
 
 
  
Richard E. Hartman, Associate Professor of Psychology 
 
 
  
 iv 
ACKNOWLEDGEMENTS 
 The completion of this dissertation would not be possible without the support and 
direction from my committee, Drs. Karen Miller, David Vermeersch, Richellin Dye, and 
Rich Hartman. Each one individually contributed in a unique way to the production of 
this project and my development as a researcher, clinician, and professional. 
Dr. Miller has been the backbone to the formulation and completion of this 
dissertation. She has been a remarkable mentor and role model. I am grateful for her vast 
knowledge within the area of neuropsychology and specifically memory disorders. I am 
also thankful for the support and encouragement of Dr. Vermeersch, who helped me 
think critically about the clinical relevance of my project. Dr. Dye has been an 
inspirational role model. Her warmth and care have been instrumental in my success 
through this project. I am also grateful for Dr. Hartman and his insights related to the 
field of neuroscience. I thoroughly appreciate his keen sense regarding the value of my 
project within the current body of research. Additionally, I would like to thank my 
colleagues, Drs. Eric Hanson and Ann Gottuso, for the guidance, support, and 
consultation they graciously provided throughout my dissertation project. 
I am also thankful for my entire family; they have been a vital source of support 
and encouragement throughout my graduate career and this project. I am grateful for their 
understanding while I devoted much of my time to my graduate studies. Thank you all for 
believing in me, encouraging me, and supporting me as I pursue my passion of becoming 
a neuropsychologist. I am indebted to my wonderful husband, Drake for his abiding love 
and support; thank you for your dedication to me, my graduate training, and my 
dissertation project. I love you. We did it! I would also like to thank my dearest friends, 
 v 
Drs. Linnea Esselstrom and Octaviana Hemmy Asamsama, for their unwavering 
friendship and support, and for the cherished memories we have created along the way.  
I would like to acknowledge my Jesus for His grace, truth, and promises. He is the 
foundation of my strength, dedication, and passion to serve others. “Each one should use 
whatever gift he has received to serve others, faithfully administering God’s grace in its 
various forms.” (1 Peter 4:10) 
            I dedicate this dissertation to my three wonderful grandmothers, Florence Grace 
Jones, Eleanor Marie Farace and Alta Mae Picket, two of which developed dementia in 
their later life. It is my hope that this research will ultimately serve as an aid in early 
detection of memory disorders, permitting an opportunity for early intervention. 
  
 vi 
CONTENT 
 
Approval Page .................................................................................................................... iii 
 
Acknowledgments.............................................................................................................. iv 
 
List of Tables ..................................................................................................................... ix 
 
Abstract ................................................................................................................................x 
 
Chapter 
 
1. Review of the Literature ..........................................................................................1 
 
Alzheimer’s Disease ......................................................................................... 1 
 
Risk Factors .................................................................................................1 
Healthcare Costs ..........................................................................................3 
Neurological Profile of AD ..........................................................................4 
Neuropsychological Profile of AD ..............................................................8 
 
Mild Cognitive Impairment .............................................................................11 
Assessment of Conversion to MCI and Alzheimer’s Disease .........................13 
 
Verbal Memory ..........................................................................................15 
Visual Spatial Memory ..............................................................................18 
Executive....................................................................................................19 
Language ....................................................................................................20 
 
Aims & Hypotheses .........................................................................................22 
 
2. Methods and Procedures ........................................................................................24 
 
Participants .......................................................................................................24 
 
Recruitment ................................................................................................24 
Inclusion/Exclusion....................................................................................24 
 
Instrumentation ................................................................................................24 
 
Verbal Memory ..........................................................................................25 
 
Buschke Selective Reminding Test .....................................................25 
 
Visual Memory ..........................................................................................25 
 
 vii 
Rey-Osterrieth Complex Figure Test ...................................................25 
 
Executive Functioning ...............................................................................27 
 
Trail Making Test B .............................................................................27 
 
Language ....................................................................................................27 
 
Semantic Fluency (Animals) ................................................................27 
Boston Naming Test‒2 ........................................................................27 
 
IQ ...............................................................................................................28 
 
Wechsler Test of Adult Reading ..........................................................28 
 
Mood ..........................................................................................................28 
 
Hamilton Depression Rating Scale ......................................................28 
 
 
Procedures ........................................................................................................29 
 
Data Analysis and Procedures ...................................................................29 
 
Statistical Analysis ...............................................................................30 
 
3. Results ....................................................................................................................32 
 
Sample Characteristics .....................................................................................32 
Aim 1 ...............................................................................................................32 
 
Hypothesis 1.1............................................................................................33 
Hypothesis 1.2............................................................................................34 
Hypothesis 1.3............................................................................................34 
Hypothesis 1.4............................................................................................35 
 
Aim 2 ...............................................................................................................38 
 
Hypothesis 2.1............................................................................................39 
Hypothesis 2.2............................................................................................39 
 
4. Discussion ..............................................................................................................40 
 
Purpose of the Study ........................................................................................40 
Findings............................................................................................................40 
Limitations .......................................................................................................44 
 viii 
Implications......................................................................................................44 
Conclusion .......................................................................................................45 
 
References ..........................................................................................................................47 
 
  
 ix 
TABLES 
 
Tables Page 
 
1. Descriptive Characteristics of the Sample .............................................................32 
2. Correlations Between Neuropsychological Tests ..................................................33 
3. Univariate Binary Logistic Regression Predicting Conversion from 
Normal Aging to MCI ............................................................................................33 
4. Multivariate Logistic Regression Predicting Conversion from Normal 
Aging to MCI .........................................................................................................34 
5. Univariate Binary Logistic Regression Predicting Conversion from 
Normal Aging/MCI to Probable Alzheimer’s Disease ..........................................35 
6. Multivariate Logistic Regression Predicting Conversion from Normal 
Aging/MCI to Probable Alzheimer’s Disease .......................................................36 
7. Comparison demographic data from demographically matched non-
converters and converters to MCI ..........................................................................36 
8. Comparison demographic data from demographically matched non-
converters and converters to AD ............................................................................37 
9. Univariate Binary Logistic Regression Predicting Conversion from 
Normal Aging to MCI ............................................................................................38 
10. Univariate Binary Logistic Regression Predicting Conversion from 
normal/MCI to AD .................................................................................................38 
11. Univariate Binary Logistic Regression Predicting Conversion from 
Normal Aging to MCI ............................................................................................39 
12. Univariate Binary Logistic Regression Predicting Conversion from 
Normal Aging/MCI to Probable Alzheimer’s Disease ..........................................39 
  
 x 
ABSTRACT OF THE DISSERTATION 
Predicting Cognitive Decline in Older Adults  
 
by 
 
Kimberly M. Baerresen 
 
Doctor of Philosophy, Graduate Program in Clinical Psychology 
Loma Linda University. September 2014 
Karen J. Miller, Ph.D. and David A. Vermeersch, Ph.D., Chairpersons 
 
The investigator sought to determine which neuropsychological tests are more 
likely to predict an individual’s cognitive decline (i.e., normal to mild cognitive 
impairment, mild cognitive impairment to Alzheimer’s disease) two years prior to 
conversion. A sample of non-decliners (N=109) compared to those who declined (N=24) 
in cognitive status (i.e., mild cognitive impairment or Alzheimer’s disease) with a mean 
age of 61.44 (SD=11.29) was examined. Results indicate the Rey-Osterrieth Complex 
Figure Test, Retention Trial (RCFT Retention; OR=0.93, p=0.005) is a significant 
predictor of conversion to MCI and the Buschke Delay (OR=0.54, p=0.017) is a 
significant predictor of conversion to AD. Due to group sample size difference, additional 
analyses were conducted utilizing a subsample of demographically matched non-
decliners. Results indicate the RCFT Retention is a significant predictor of conversion to 
MCI (OR=0.94, p=0.019) and AD (OR=0.90, p=0.048) and Buschke Delay (OR=0.68, 
p=0.027) is a significant predictor of conversion to AD. Given the results of this 
dissertation, it may be important for clinicians/researchers to monitor these measures for 
the purpose of predicting cognitive decline. 
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CHAPTER ONE 
REVIEW OF THE LITERATURE 
 
Alzheimer’s Disease 
According to the National Institute on Aging (2011), Alzheimer’s disease is “a 
progressive, degenerative disorder that attacks the brain's nerve cells, or neurons, 
resulting in loss of memory, thinking and language skills, and behavioral changes.” It was 
estimated that approximately 5.4 million Americans of all ages will have Alzheimer’s 
disease in 2012. This figure includes 5.2 million people age 65 and older (Hebert, Scherr, 
Bienias, Bennett, & Evans, 2003), and 200,000 individuals under age 65 who have 
younger onset Alzheimer’s disease (Alzheimer’s Association, 2006). Most people in the 
United States living with Alzheimer’s disease and other dementias are non-Hispanic 
whites; however, older African-Americans and Hispanics are proportionately more likely 
than older whites to have Alzheimer’s disease and other dementias (Dilworth-Anderson, 
Hendrie, Manly, Khachaturian, & Fazio, 2008; Manly & Mayeux, 2004). Data specify 
that in the United States, older African-Americans are probably about twice as likely to 
have Alzheimer’s disease and other dementias as older whites, (Potter et al., 2009) and 
Hispanics are about one and one-half times as likely to have Alzheimer’s disease and 
other dementias as older whites (Gurland et al., 1999). 
 
Risk Factors 
Researchers have identified specific factors which place one at risk for developing 
Alzheimer’s disease. The Alzheimer’s Association (2012) reported that the greatest risk 
factor for Alzheimer’s disease is advancing age, reporting that most people with 
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Alzheimer’s disease are diagnosed at age 65 or older. Braak, Braak, Bhol & Reintjes 
(1996) studied 2,222 brains upon autopsy and found that neurofibrillary pathology (the 
hallmark of Alzheimer’s disease) multiplies with age. The Alzheimer’s Association 
(2012) reported that family history of Alzheimer’s disease also places one at risk. The 
Multi-Institutional Research in Alzheimer Genetic Epidemiology project support this 
notion; 1,694 patients who met criteria for probable or definite Alzheimer’s disease were 
examined, and it was found that lifetime risk of Alzheimer’s disease in first-degree 
relatives was 39% by age 96 years. Furthermore, it was found that by age 80, children of 
conjugal Alzheimer’s disease couples had a cumulative risk of 54%, 1.5 times greater 
than the sum of the risks to children having affected mothers or fathers, and nearly 5 
times greater than the risk to children having unaffected parents (Lautenschlager et al. 
1996). Individuals with the e4 form of the gene apolipoprotein E (APOE) are also at 
increased risk of developing Alzheimer’s disease (Alzheimer’s Association, 2012). 
APOE-e4 is one of three common forms (e2, e3 and e4) of the APOE gene, which 
provides the blueprint for a protein that carries cholesterol in the bloodstream. While 
everyone inherits one form of the APOE gene from each parent, research has found that 
individuals who inherit APOE –e4 are at increased risk of AD by a factor of 2.84 for each 
additional APOE-e4 allele (Corder et al., 1993). Hence, subjects with two APOE -e4 
genes were more than eight times as likely to be affected as subjects with e2 or e3 
genotypes. It was also found that with each additional APOE-e4 allele shifted onset of 
Alzheimer’s to a younger age; mean onset was 84.3 years in subjects who did not have 
APOE-e4, 75.5 years in subjects with one APOE-e4, and 68.4 years in subjects with two 
APOE-e4 alleles. (Corder et al., 1993). The National Institute on Aging reported that 
 3 
APOE -e4 is present in about 25 to 30 percent of the population and in about 40 percent 
of all people with late-onset Alzheimer's.  
Research also indicates chronic depression as a risk factor for the development of 
Alzheimer’s disease (Andersen, Lolk, Kragh-Sorensen, Petersen, & Green, 2006; 
Geerlings et al., 2000; Speck et al., 1995; Steenland et al., 2012). More specifically, 
Steenland et al. (2012) studied over 5,000 subjects at 30 different Alzheimer’s disease 
centers and found that having depression throughout the six years of the study was a 
significant risk for developing MCI (for those who were initially cognitively intact) or 
Alzheimer’s disease (for those who initially had MCI) compared to those that did not 
have depression. Geerlings et al, (2000) examined two independent samples of older 
people with normal cognition from the community-based Amsterdam Study of the 
Elderly and the Longitudinal Aging Study Amsterdam and found that those with severe 
depressive symptoms had 5.31 times the risk of developing Alzheimer’s disease, but only 
in subjects with higher levels of education. They concluded that in a subgroup of more 
highly educated elderly people, depression may be an early manifestation of Alzheimer's 
disease before cognitive symptoms become apparent as cognitive symptoms may not 
initially manifest themselves due to the impact of cognitive reserve (e.g., higher 
education).  
 
Healthcare Costs 
 Not only is Alzheimer’s disease prevalent, it is potentially deadly and its 
healthcare costs are climbing. Alzheimer’s disease is the sixth leading cause of death in 
the United States. Based on 2008 final data from the National Center for Health Statistics, 
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Alzheimer’s disease was reported as the underlying cause of death for 82,435 people. 
(Miniño A, 2011). However, death certificates for individuals with Alzheimer’s disease 
often list acute conditions as the primary cause of death rather than Alzheimer’s disease 
(Macera, Sun, Yeager, & Brandes, 1992; Olichney, Hofstetter, Galasko, Thal, & 
Katzman, 1995; Wachterman, Kiely, & Mitchell, 2008). Thus, Alzheimer’s disease is 
likely a contributing cause of death for even more Americans than indicated by 
government data. Aggregate payments for health care, long-term care and hospice for 
people with Alzheimer’s disease and other dementias are projected to increase from $200 
billion in 2012 to $1.1 trillion in 2050 (in 2012 dollars). Medicare and Medicaid cover 
about 70 percent of the costs of care (Alzheimer’s Association, 2010). 
 
Neurological Profile of AD 
The National Institute of Neurological Disorders and Stroke (2012) indicates that 
Alzheimer’s disease includes three major components of the disease process: 1) amyloid 
plaques, 2) neurofibrillary tangles, and 3) loss of connections between neurons 
responsible for memory and learning. Amyloid plaques are fragments of a protein called 
beta-amyloid peptide mixed with a collection of additional proteins, remnants of neurons, 
and bits and pieces of other nerve cells. Neurofibrillary tangles are formed by 
hyperphosphorylation of a microtubule-associated protein known as tau, causing it to 
aggregate, or group, in an insoluble form. This aggregated, insoluble tau protein (tau 
tangles) are found inside neurons, and cause dysfunction within neurons and ultimately 
lead to neuronal death. The loss of connections between neurons responsible for memory 
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and learning cause neuronal death; as neurons die throughout the brain, the affected 
regions begin to shrink.  
The gradual process of brain deterioration due to these amyloid plaques and 
neurofibrillary tangles begins in a few limbic areas of the cortex and then spreads in a 
predictable, nonrandom manner across the hippocampus and neocortex. According to 
researchers, this sequence of changes shows little individual variation and thus provides 
the basis for distinguishing six stages in the development of neurofibrillary tangles 
(Braak & Braak, 1991). Braak & Braak (1991) determined six stages characterizing the 
progression and location of tau tangles in the brain. Braak stage one is the point at which 
tau protein starts to gather into tau tangles. The tau tangles have begun to form in the 
transitional entorhinal region in the medial temporal lobe. This is a "relay station" 
between the cortex and the hippocampus, which is critical for memory. There are no 
external symptoms at this stage; however, from this point, further decline is inevitable. 
By Braak stage two, tau tangles have accumulated further and have caused some neurons 
to die. At this stage, the tau tangles are much more extensive in the transitional entorhinal 
region and have begun to kill neurons here. In the hippocampus and neocortex, tau 
protein is also beginning to aggregate at this stage, but has not yet formed tangles. 
Cognitive testing at this stage would show minimal impairment. Tangles at this level or 
worse are found in the brains of about 60% of individuals over the age of 65. By Braak 
stage 3, the tau tangles have begun to cause extensive neuronal death. The tau protein has 
formed extensive tangles in the transitional entorhinal region, has also aggregated and 
begun to form tangles in the hippocampus, and is beginning to aggregate in the 
neocortex. At this stage, tau tangles and neuronal death have likely caused some memory 
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impairment, but only about 10% of patients at this stage will be diagnosed as suffering 
from dementia. Approximately 45% of individuals who are 80 years old have reached 
this stage. By Braak stage 4, the tau tangles have formed extensively in the transitional 
entorhinal region and the hippocampus where they have caused neuronal death, and they 
are starting to form in the neocortex. The neocortex is the largest part of the brain, and is 
involved in higher functions such as sensory perception, conscious thought and language. 
Even though the tau tangles still occupy only a small portion of the brain, they have 
caused significant memory and cognitive impairment. Seventy-percent of patients with 
this level of tangles in their brain will be diagnosed as suffering from dementia. At Braak 
stage 5, the tau tangles have caused extensive neuronal death, giving rise to severe 
memory and cognitive impairment. Tangles have expansively formed in the transitional 
entorhinal region, the hippocampus, and the neocortex. Approximately 80% of patients 
with this level of tangles will be diagnosed as suffering from moderate to severe 
dementia. By Braak stage 6, tau tangles have formed extensively in the transitional 
entorhinal region, the hippocampus, and the neocortex. The tau tangles have caused 
extensive neuronal death. All patients with this many tangles in their brain will be 
diagnosed as suffering from severe dementia. These individuals will be completely 
unable to take care of themselves and will have trouble recognizing family members. In 
sum, tau protein tangles initially begin to accumulate in the entorhinal region (“relay 
station” between the hippocampus and neocortex), the tangles then spread to the 
hippocampus (memory center) and neocortex (responsible for higher functions such as 
sensory perception, conscious thought and language).  
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Although the advancement of Alzheimer’s disease initiates via brain deterioration 
in a few limbic areas of the cortex and then spreads in a predictable, nonrandom manner 
across the hippocampus and neocortex in men and women, women are disproportionally 
affected (Thies & Bleiler, 2013). The prevalence of AD is significantly higher in women 
compared to men. Recent estimates suggest that almost two-thirds of the individuals 
diagnosed with AD are women (Hebert et al., 2003). A reason for the higher prevalence 
among women may be that they live longer, on average, than men (Plassman et al., 2007; 
Seshadri et al., 1997). In contrast to these studies, the Cache County Study, did report a 
higher incidence of AD in men than women until age (van Amelsvoort, Compton, & 
Murphy, 2001), after which women had a higher incidence than men (Miech et al., 2002). 
Similarly, the Mayo Clinic Study of Aging recently reported that the rate of progression 
from MCI to AD was similar in men and women aged (Cosgrove, Mazure, & Staley, 
2007; Giedd, Castellanos, Rajapakse, Vaituzis, & Rapoport, 1997; Good et al., 2001; 
Gur, Gunning-Dixon, Turetsky, Bilker, & Gur, 2002; Luders, Gaser, Narr, & Toga, 2009; 
Pfefferbaum et al., 2013; van Amelsvoort et al., 2001; Witte, Savli, Holik, Kasper, & 
Lanzenberger, 2010), but higher in women than men after age 80 (Roberts et al., 2014). 
However, in patients with AD, brain volumes have been found to decline faster in women 
than men (Skup et al., 2011).  
In the context of cerebral metabolic deficits associated with cognitive impairment 
in dementia, two studies have shown that men have more pronounced cerebral metabolic 
deficits compared to women at the same level of cognitive impairment, suggesting that 
the greater brain reserve in men may be helping them withstand more pathology than 
women at the same level of dementia severity (Perneczky, Diehl-Schmid, Forstl, 
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Drzezga, & Kurz, 2007; Perneczky, Drzezga, Diehl-Schmid, Li, & Kurz, 2007). 
Furthermore, three studies reported women with one ε4 allele had about a four-fold risk 
of AD, whereas men with one ε4 allele showed little increased risk (Bretsky et al., 1999; 
Farrer et al., 1997; Payami et al., 1996). The APOE ε4 allele also has a greater deleterious 
effect on hippocampal pathology, functional connectivity changes in the default mode 
network, cortical thickness, and memory performance in women compared with men at 
different stages of AD (Damoiseaux et al., 2012; Fleisher et al., 2005; Liu et al., 2010). 
Additionally, a large autopsy study found that amyloid plaque and neurofibrillary tangle 
pathology was greatest among women who were ε4 carriers (Corder et al., 2004). 
 
Neuropsychological Profile of AD 
The neuropsychological profile of Alzheimer’s disease typically includes decline 
in memory, language and semantic knowledge, working memory, attention, and visual 
spatial abilities, ultimately impacting all aspects of cognitive functioning. 
Evidence has demonstrated that patients with Alzheimer’s disease have 
impairments in episodic memory. These impairments have been displayed with various 
cognitive procedures, such as free recall, recognition, and paired-associate learning 
(Salmon, 2000). It is hypothesized that these deficits are primarily due to dysfunction in 
the consolidation or storage of new information. One such study found that recall after a 
10-minute delay on a list learning task accurately classified 90% of early Alzheimer’s 
disease participants (Welsh, Butters, Hughes, Mohs, & Heyman, 1991). Furthermore, 
empirical evidence has implicated factors that may be contributing to impairments in 
consolidation. For example, several studies demonstrated that those with Alzheimer’s 
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disease have a heightened susceptibility to interference, likely due to decreased inhibitory 
process (Bayles & Tomoeda, 1983; Delis et al., 1991; Fuld, Katzman, Davies, & Terry, 
1982; D. Jacobs, Salmon, Troster, & Butters, 1990).  
A second impairment commonly seen in those with Alzheimer’s disease is within 
the cognitive domain of language. Specifically, studies have shown that those with 
Alzheimer’s disease show reduced performances on tests of object naming (Bowles, 
Obler, & Albert, 1987; Hodges, Salmon, & Butters, 1991; Martin & Fedio, 1983), verbal 
fluency (Butters, Granholm, Salmon, Grant, & Wolfe, 1987; Martin & Fedio, 1983; 
Monsch et al., 1992), and semantic categorization (Aronoff et al., 2006). This may be due 
to the deterioration of components that support language such as the structure and content 
of semantic memory. As the dementia process progresses neurologically to include the 
temporal, frontal, and parietal cortices, knowledge for specific information and ideas and 
the relationships between them may be interrupted (Hodges & Patterson, 1995). Several 
studies have demonstrated impairment of semantic memory through examining fluency, 
confrontation naming, sorting, word-to-picture matching, and definition generation. 
Evidence for a deterioration of semantic memory in Alzheimer’s disease comes from 
several studies that assessed knowledge of particular concepts across different modes of 
access and output (e.g., fluency, confrontation naming, sorting, word-to-picture matching, 
and definition generation). Because deficits have been observed across varying 
modalities of language tests, it has been hypothesized that loss of knowledge regarding 
the presented information is the contributing factor rather than an inability to retrieve 
such information (Chertkow & Bub, 1990; Hodges, Salmon, & Butters, 1992). These 
researchers found that those with Alzheimer’s disease were impaired on all tasks of 
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semantic memory; furthermore, answers were consistent across tests, such that when a 
specific item was incorrectly or correctly answered on one task, it was likely to be 
answered in the consistently in other tasks that assessed the same information in a 
different way. In sum, researchers have concluded that the information within these tests 
is no longer existent among those with Alzheimer’s disease—rather than merely 
inaccessible.  
Executive functioning, working memory, and attention are also reduced in those 
with Alzheimer’s disease, which is commonly attributed to neurofibrillary tangle burden 
in the prefrontal cortex. Evidence suggests that those with Alzheimer’s disease have 
reduced functioning on problem solving tests that require mental manipulation (Bondi, 
1993; Grady et al., 1988; Lange, Sahakian, Quinn, Marsden, & Robbins, 1995; Waltz et 
al., 2004). Reduced mental manipulation performance may also be conveyed on working 
memory tasks (Baddeley, Bressi, Della Sala, Logie, & Spinnler, 1991; Collette, Van der 
Linden, Bechet, & Salmon, 1999). Furthermore, those with Alzheimer’s disease 
frequently have reduced performance on complex attention tasks that rely on the 
appropriate use of attentional resources or that require adequate shifting of attention 
(Parasuraman R., 1993; Perry & Hodges, 1999). In sum, the working memory and 
attentional impairments observed in those with Alzheimer’s disease are secondary to the 
executive deficits.  
Morrison and colleagues (1991) have proposed that visuoperceptual deficits in 
those with Alzheimer’s disease may be related to deteriorated association between 
distinct and intact cortical information process systems (Morrison, Hof, & Bouras, 1991). 
Additional research has supported this notion; studies have shown that those with 
 11 
Alzheimer’s disease have reduced performance on a visual search task where they were 
required to quickly identify targets on the basis of the combination of two or more 
features that are processed in different cortical regions (e.g., color and shape). Those with 
Alzheimer’s disease have greater response times compared to controls than when 
required to identify targets solely on the basis of a single feature (Foster, Behrmann, & 
Stuss, 1999; Treisman, 1996). Subsequent studies showed that this deficit in “feature-
binding” (Foster et al., 1999; Treisman, 1996) could not be attributed to the different 
attentional demands inherent in conjunction versus single-feature visual search tasks 
(Tales et al., 2002). In sum, research suggests that the visuoperceptual deficits observed 
in those with Alzheimer’s disease is related to problems with information processing 
between cortical regions rather than deficits within the region itself.  
Although neuropsychological profiles of men and women are similar, it is 
important to note that consistent cross-sectional difference at all ages is that women 
perform better on verbal memory tasks and men perform better on visuospatial tasks 
(Proust-Lima et al., 2008; van Hooren et al., 2007). 
 
Mild Cognitive Impairment 
It is evident that Alzheimer’s disease is prevalent, deadly, and costly. 
Neurocognitively, there are changes that healthcare professionals may identify early in 
the disease process to initiate intervention opportunities—the question is, how early on is 
this possible? The literature is saturated with data regarding Mild Cognitive Impairment 
(MCI); oftentimes classifying it as the pre-dementia stage. Mild Cognitive Impairment is 
a distinct classification that falls between healthy aging and dementia (Petersen et al., 
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1999). The literature in the field defines MCI as having a memory complaint, normal 
activities of daily living (ADLs), normal general cognitive functioning, abnormal 
memory for age, and absence of dementia (Petersen et al., 1999; Tierney et al., 1996). 
Petersen and colleagues (1999) found that memory function distinguishes those who are 
aging normally from those who have MCI; while the other cognitive domains are 
comparable. They also found that when compared to those with mild Alzheimer’s 
disease, those with MCI were similar with regards to memory function, but those with 
mild Alzheimer’s disease were more impaired in other cognitive domains. Criteria and 
guidelines for diagnosis of Alzheimer’s disease, published in 2011, suggest that in some 
cases MCI is actually an early stage of Alzheimer’s (Albert et al., 2011; Jack et al., 2011; 
McKhann et al., 2011; Sperling et al., 2011). In sum, MCI is a distinct classification of 
cognitive impairment and those who develop MCI with primarily amnestic features are 
more likely to develop Alzheimer’s disease. It is estimated that approximately 10-15% of 
individuals diagnosed with MCI convert to AD every year (e.g., Levey et al., 2006). 
Studies indicate that as many as 10 to 20 percent of people age 65 and older 
experience MCI (Hanninen, Hallikainen, Tuomainen, Vanhanen, & Soininen, 2002; 
Lopez et al., 2003; Roberts et al., 2008). As mentioned above, further cognitive decline is 
more likely among individuals whose MCI involves amnestic features than in those 
whose MCI does not involve amnestic features. Over one year, most individuals with 
MCI who are identified through community sampling remain cognitively stable, while 
some, primarily those without memory problems, experience an improvement in 
cognition or revert to normal cognitive status (Ganguli et al., 2011). However, nearly one 
third of all people who report MCI symptoms will develop Alzheimer’s disease in three 
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or four years (Petersen et al., 1999). Therefore, it is important that people experiencing 
cognitive decline are identified by their healthcare practitioner to implement early 
intervention and facilitate reversion to normal cognitive status or, at the minimum, halt 
the progression of cognitive decline. It is important to note that this early identification is 
also critical for researchers in the field. It is critical to study those who develop 
Alzheimer’s disease at the earliest stages to better understand the progression, thus 
facilitating the development of treatment. Studies have found that early intervention (at 
the Mild Cognitive Impairment stage), a healthy diet (e.g., increased fish, omega-3 
supplements) and participating in cognitively stimulating activities (reading, writing, 
crossword puzzles, board or card games, group discussions or playing music) may delay 
the progression to dementia (Blasko et al., 2012; Cheng et al., 2013; Lee et al., 2013; 
Miller et al., 2012; Roberts et al., 2008; Roberts et al., 2012; Wenisch et al., 2007).  
 
Assessment of Conversion to MCI and Alzheimer’s Disease 
According to the American Health Assistance Foundation, at the present time, an 
autopsy is needed in order to definitely diagnose Alzheimer’s disease. However, while a 
person is alive, physicians can correctly diagnose Alzheimer's disease about 90 percent of 
the time based collectively on neuroimaging, neuropsychological tests, laboratory tests, 
and symptoms reported. However, as stated previously, it is important to detect those 
who may develop Alzheimer’s disease before the disease process has more fully 
actualized. With regards to neuroimaging, recent studies have shown that PET scans 
using specific tracers (FDDNP and C-PIB) have been successful in the early 
classification of cognitive decline. More specifically, these tracers have the ability to 
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accurately classify those who are aging normally, have mild cognitive impairment, and 
dementia of the Alzheimer’s type (Bateman et al., 2012; Ercoli et al., 2012; Klunk et al., 
2004; Small et al., 2006; Small et al., 2012; Wolk et al., 2012). While these findings are 
hopeful, it is unclear as to when such techniques will be used on clinical, rather than 
research, populations and how accessible and feasible such scans will be for patients at 
the early stages of cognitive decline.  
Of particular importance to the neuropsychologist are neuropsychological 
measures, specifically with regards to their effectiveness in detecting cognitive decline. 
When assessing for changes in cognitive functioning early on, neuropsychological 
batteries have been shown to detect such changes. However, neuropsychological batteries 
can be costly and time-consuming for the patient and thus it may not be efficient in 
providing such testing as a “screener” for early signs of cognitive decline. Certain 
“screeners” have been used in order to determine whether one has dementia (e.g., Mini 
Mental Status Exam, Montreal Cognitive Assessment). One study examined whether the 
Montreal Cognitive Assessment (MoCA) and Mini Mental Status Exam (MMSE) could 
detect MCI. The results indicated that the MMSE had a sensitivity of 18% to detect MCI, 
whereas the MoCA detected 90% of MCI subjects (Levey, Lah, Goldstein, Steenland, & 
Bliwise, 2006). Thus, these results suggest that the MoCA is a more sensitive measure for 
detecting MCI as compared to the MMSE. Another study has found similar results (Q. H. 
Guo et al., 2010). However, the ability of either of these tests to detect the earliest signs 
of cognitive decline (those present prior to MCI) and those found specifically among 
those who may develop Alzheimer’s disease is not yet known.  
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There may be specific neuropsychological tests that have the ability to accurately 
classify patients who will convert from normal aging to amnestic mild cognitive 
impairment or from amnestic mild cognitive impairment to dementia of the Alzheimer’s 
type. Researchers have determined that several different neuropsychological tests have 
the ability to predict such conversion. For example, verbal memory of lists of words such 
as the California Verbal Learning Test (Albert, Moss, Tanzi, & Jones, 2001; Beck, 
Gagneux-Zurbriggen, Berres, Taylor, & Monsch, 2012; Rabin et al., 2009; Silva et al., 
2012), Auditory Verbal Learning Test (Landau et al., 2010), Rey Auditory Verbal 
Learning Test (Tierney, Yao, Kiss, & McDowell, 2005), Neurological Assessment 
Battery List Learning Test (Gavett et al., 2010), and the Buschke Selective Reminding 
Task (Devanand et al., 2008; Grober, Lipton, Hall, & Crystal, 2000; Masur, Sliwinski, 
Lipton, Blau, & Crystal, 1994; Sarazin et al., 2007; Tabert et al., 2006); verbal memory 
of word pairs such as the Semantic Object Retrieval Test (Kraut et al., 2007) and 
Wechsler Memory Scale’s Verbal Paired Associates (Venneri et al., 2011); verbal 
memory of short stories with Wechsler Memory Scale’s Logical Memory (Rabin et al., 
2009), verbal long-term memory with the Wechsler’s Adult Intelligence Scale’s 
Information (Tierney et al., 2005), and verbal memory when cued with the RI-48 Test 
(Hanseeuw & Ivanoiu, 2011); visual memory such as the immediate recall of the figures 
from Wechsler Memory Scales (Albert et al., 2001) and the Rey-Osterrieth Complex 
Figure Test (Alladi, Arnold, Mitchell, Nestor, & Hodges, 2006; Borroni et al., 2006; Guo, 
Zhao, Chen, Ding, & Hong, 2009) ; executive functioning tests such as Trails B  (Albert 
et al., 2001; Chen et al., 2000; Dickerson, Sperling, Hyman, Albert, & Blacker, 2007; 
Ewers et al., 2012; Zhou, Nakatani, Teramukai, Nagai, & Fukushima, 2012), digit symbol 
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(Tabert et al., 2006), Stroop Color Naming (Balota et al., 2010), and digit span (Kurt, 
Yener, & Oguz, 2011); and language tests such as Animals verbal fluency (Bennett et al., 
2002; Lonie et al., 2009) and the Boston Naming Test (D. M. Jacobs et al., 1995; Kraut et 
al., 2007) . Based on these findings, there are deficits evident in three main cognitive 
domains that seem to predict conversion to dementia of the Alzheimer’s type: verbal and 
visuospatial memory, executive function and language, with most of the research focusing 
on verbal memory of lists and contextual information. 
 
Verbal Memory 
Between the tests that have been developed to assess verbal learning, the 
Selective Reminding Test (SRT; Buschke, 1973) is the only measure that provides a 
distinctive form of feedback (Ruff, Light, & Quayhagen, 1989). On each subsequent trial 
after the first presentation of the entire list, which usually consists of 12 unrelated words, 
only the words that were not previously recalled are presented by the examiner. However, 
the subject must still attempt to recall the entire word list, with the learning criterion of 
SRT being the recall of all 12 words for two consecutive trials or the completion of 12 
trials in case of unattainable performance. After the learning trials, cued recall, and 
multiple recognition trials, a 30-min delayed free recall trial is administered. Due to the 
multiple-trial list-learning procedure with selective reminders and the separate scores 
derived, the SRT allows the differentiation of retention, storage, and retrieval information 
(Lezak, Hokvieson, & Loring, 2004), as well as the simultaneous assessment of several 
components of memory and learning (Spreen & Strauss, 1998). Scores include Total 
Recall, Long-term Storage, Long-term Recall, Short-term Recall, Consistent Long-term 
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Recall, Random Long-term Recall, words given by the examiner the next recall attempt 
(Reminders), words that are not in the word list presented (Intrusions), as well as Cued 
Recall, Multiple-choice Recall, and Delayed Recall.  
Given that selective reminding is a procedure, not a specific test, many versions 
have been developed since its introduction by Buschke (1973), varying, for example, the 
number of trials [12-trial or six-trial version (Larrabee, Trahan, Curtiss, & Levin, 1988; 
Larrabee, Trahan, & Levin, 2000), or mode of administration (oral or visual presentation 
of word list; Masur, Fuld, Blau, Thal, Levin, & Aronson, 1989). Moreover, the Selective 
Reminding Test has been used in different cultural environments (for example, Hebrew 
Selective Reminding Test by Gigi, Schnaider-Beeri, Davidson, & Prohovnik, 1999, and 
Spanish Selective Reminding Test by Campo & Morales, 2004). Age and sex-related 
influences on Selective Reminding Test performance have been found, while differences 
attributed to level of education are generally unclear. Increasing age is associated with a 
decline of performance. Females generally outperform males. Despite the inconsistencies 
reported, more highly educated subjects tend to show better performance (Spreen & 
Strauss,1998; Lezak, et al., 2004). 
There are few known studies that utilize the Buschke Selective Reminding Test to 
predict conversion to Alzheimer’s disease (e.g., Devanand et al., 2008; Tabert et al., 
2006); however, the results are promising.  Specifically, Tabert et al. examined 148 
patients who complained of memory problems (who were compared to 63-matched 
controls), the percent savings from immediate to delayed recall on the Selective 
Reminding Test and the Wechsler Adult Intelligence Scale–Revised Digit Symbol Test 
were the strongest predictors of time to conversion. The combined predictive accuracy of 
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these 2 measures for conversion by three years was 86%. Furthermore, in the three-year 
follow-up patient sample (33/126 converters), Devanand et al. (2008), found that the 
Pfeffer Functional Activities Questionnaire (FAQ; informant report of functioning), 
University of Pennsylvania Smell Identification Test (UPSIT; olfactory identification), 
Selective Reminding Test (SRT) immediate recall (verbal memory), MRI hippocampal 
volume, and MRI entorhinal cortex volume combined, demonstrated 90% specificity and 
85.2% sensitivity, and the three clinical predictors (SRT immediate recall, FAQ, and 
UPSIT) showed 81.3% sensitivity. More research is needed in order to better understand 
its ability to determine those who will develop Alzheimer’s disease. This test is of 
particular interest because in addition to measuring verbal memory, it also involves 
working memory and executive functioning. The words within the list are not easily 
categorized and thus, it requires the examinee to create categorization.  
 
Visual Spatial Memory 
The Rey Complex Figure Test, RCFT (Meyers, Bayless, & Meyers, 1996) 
Osterrieth, 1945; Rey, 1941), measures visuospatial and visuoconstructional abilities, 
perceptual organization and planning (executive functioning), and visual memory. The 
patient is presented a stimulus card containing a complex figure which is composed of 
basic shapes and elements. He or she is asked to copy this drawing as precisely as 
possible on a blank sheet of paper. Without prior warning, the patient is then asked to 
draw the figure again from memory after a three-minute delay and again after a 30-
minute delay (Immediate Recall and Delayed Recall).  
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Alladi et al. studied 124 patients with memory deficit who were non-demented by 
using the RCFT Complex Figure Test, and found that the MCI discrimination rate of 
delayed recall was 72%. Furthermore, Guo and colleagues (2009) found that the RCFT 
Complex Figure Test also predicted conversion from MCI to Alzheimer’s disease among 
a sample of Chinese patients; however, they found that the RCFT accurately classified 
only 27% of patients and found that a list learning task was better at predicting 
conversion among this population. Although few studies have examined the RCFT 
Complex Figure Test as a predictor of conversion to Alzheimer’s disease, the results 
suggest it may in fact be adequate in doing so. The Rey Complex Figure Test is of 
particular interest because, like the SRT, it likely measures executive functioning; the test 
requires the patient to recall the complex figure by drawing it, this involves organizing 
and planning in addition to visuospatial memory.  
 
Executive 
Measures of cognitive flexibility are recognized as effective tools for assessing 
executive dysfunction among those with Alzheimer’s disease, along with other brain 
degenerative disorders. As mentioned previously, there are verbal and visual memory 
tasks that may require some executive abilities. One common tool utilized specifically to 
measure executive functioning is the Trail Making Test B (TMT-B). The Trail Making 
Test was originally designed as part of the Army Individual Test Battery (1944) and is 
now included in several general and specific-purpose neuropsychological test batteries 
(Reitan, 1994). The TMT-B involves drawing a line, connecting alternating numbers and 
letters in sequence (i.e., 1-A-2-B and so on). The time to complete the ‘trail’ is recorded.  
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The Trail Making Test B has been shown to be a powerful predictor of conversion 
to Alzheimer’s disease. For instance, Chapman et al. (2010) examined individuals with 
MCI who later converted to Alzheimer’s disease; the Trail Making Test B was the second 
most effective predictor of conversion, second to a memory test. Furthermore, Rozzini et 
al. (2007) examined 119 subjects who met criteria for MCI-amnestic only and found that 
the Trail Making Test B predicted conversion to Alzheimer’s disease even better than 
memory tests (Rozzini et al., 2007).  
 
Language 
Tests of verbal fluency are widely used to assess cognitive functioning and are 
viewed as sensitive measure of language dysfunction in Alzheimer’s disease. Depending 
on the type of fluency task, participants are asked to retrieve words that start with a 
specific letter (e.g., FAS: phonemic fluency) or words that belong to a semantic category 
(e.g., animals, clothing), typically, over a one minute period. It has long been known that 
naming is impaired at an early stage in Alzheimer’s disease (Bayles, Tomoeda, & 
Trosset, 1990; Martin & Fedio, 1983); however, this is true also of phonemic fluency 
(Adlam, Bozeat, Arnold, Watson, & Hodges, 2006) and impaired semantic fluency has 
been viewed as a sign of early semantic degradation in pre-symptomatic Alzheimer’s 
disease patients (Chen et al., 2001) and those with Mild Cognitive Impairment (Adlam et 
al., 2006). Indeed, Adlam et al. (2006) recently reported that semantic fluency was the 
only test of semantic functioning that significantly differentiated individuals with Mild 
Cognitive Impairment from healthy controls. A major finding in the Alzheimer’s disease 
literature has been the documentation of a differentially greater semantic than phonemic 
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fluency impairment (Henry et al., 2004). It has been widely argued that semantic fluency 
is disproportionately impaired in Alzheimer’s disease, while phonemic fluency is usually 
less impaired (Crossley, D'Arcy, & Rawson, 1997; Martin & Fedio, 1983; Monsch et al., 
1992; Salmon, Heindel, & Lange, 1999) or even intact (Butters et al., 1987). The 
relatively greater impairment of semantic over phonemic fluency in Alzheimer’s disease 
has been used to differentiate AD from other dementias such as fronto-temporal dementia 
(Rascovsky, Salmon, Hansen, Thal, & Galasko, 2007).  
Boston Naming Test (BNT) introduced in 1983 by Drs. Edith Kaplan, Harold 
Goodglass, and Sandra Weintraub, is a widely used neuropsychological assessment tool 
to measure confrontational word retrieval (a type of semantic fluency) in individuals with 
aphasia or other language disturbance caused by stroke, Alzheimer’s disease, or other 
dementia disorders. The BNT contains 60 line drawings graded in difficulty from “bed” 
(easy, high frequency) to “abacus” (difficult, low frequency) that the patient must name. 
Like other semantic based tests (e.g., Animals), the patient must produce words; 
however, with the BNT the patient must produce the exact word, rather than having a 
choice of words within a category. With regards to conversion to Alzheimer’s disease, 
the BNT may have particular predictive ability due to its assessment of long-term 
memory. Research has found that the BNT is an effective predictor of conversion to 
Alzheimer’s disease (Howieson et al., 2003; Kraut et al., 2007); however, the studies are 
few.  
Because the Buschke Selective Reminding Test, RCFT Complex Figure Test, 
Trail Making Test B, semantic fluency (i.e. Animals), the Boston Naming Test and their 
associated cognitive domains (verbal memory, visuospatial memory, executive 
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functioning, and language) have individually demonstrated the ability to predict 
conversion to Alzheimer’s disease, the current study seeks to investigate the ability of 
these tests together, to predict conversion from normal aging to MCI and MCI to 
Alzheimer’s disease.  
 
Aims & Hypotheses 
Aim 1: To determine what neuropsychological measures best predict conversion 
from normal aging to Mild Cognitive Impairment and Mild Cognitive Impairment to 
probable Alzheimer’s disease among older adults. 
 Hypothesis 1.1: Individually, the Buschke Selective Reminding Test (Total), Rey-
Osterrieth Complex Figure Test (Delay), Boston Naming Test, Trail Making Test 
B, and Animals verbal fluency test will predict conversion from normal aging to 
MCI. 
 Hypothesis 1.2: Based on the outcome of 1.1, a multivariate model will be 
developed in which the significant tests together will predict conversion from 
normal aging to MCI.  
 Hypothesis 1.3: Individually, the Buschke Selective Reminding Test (Total), Rey-
Osterrieth Complex Figure Test (Delay), Boston Naming Test, Trail Making Test 
B, and Animals verbal fluency test will predict conversion from MCI to AD. 
 Hypothesis 1.4: Based on the outcome of 2.1, a multivariate model will be 
developed in which the significant tests together will predict conversion from 
MCI to AD. 
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Aim 2: To determine whether depression predicts conversion to a more severe 
cognitive disorder (MCI or AD). 
 Hypothesis 2.1: Incidence of depression as measured by the Hamilton 
Depression Scale at time of testing will predict conversion from normal aging to 
MCI.  
 Hypothesis 2.2: Incidence of depression as measured by the Hamilton 
Depression Scale at time of testing will predict conversion from normal aging to 
AD.  
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CHAPTER TWO 
METHODS AND PROCEDURES 
 
Participants 
The present study examined data from a convenience sample of 130 individuals, 
based on the availability of follow-up neuropsychological data. This convenience sample 
was drawn from a larger longitudinal study of mild age-related memory loss designed to 
determine neuropsychological, neuroimaging, and genetic predictors of subsequent 
cognitive decline. DNA was obtained from blood samples, and APOE genotypes were 
determined with the use of standard techniques. Investigators blind to the genetic findings 
performed all of the clinical procedures. Written informed consent was obtained in 
accordance with the procedures set by the UCLA Institutional Review Board. 
 
Recruitment 
Participants from the larger study were recruited through advertisements and 
physician referral that emphasized middle-aged and older people with memory 
complaints and family histories of dementia.  
 
Inclusion/Exclusion 
Any subjects with a neurological, medical, or psychiatric condition that could 
affect memory or other cognitive processing were excluded. Subjects with major 
depression at baseline were excluded. Standardized laboratory screening tests for a 
dementia evaluation and magnetic resonance imaging (MRI) scans were performed to 
uncover potentially treatable causes of mental impairment. To eliminate people with 
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conditions that could reduce memory performance, those with neurological and medical 
disorders or major depressive disorder were excluded from participation. The participants 
were also excluded if they scored less than 25 on the Mini-Mental Status Exam, which 
represented the criteria used for participants to be ‘asymptomatic.’ These methods of 
exclusion were based on a review of medical history, laboratory tests, and a psychiatric 
interview and evaluation. 
 
Instrumentation 
Verbal Memory 
Buschke Selective Reminding Test  
 The Buschke Selective Reminding Test (SRT) measures verbal learning and 
memory using a multiple-trial list-learning paradigm. The SRT involves reading to the 
subject a list of words and then having the subject recall as many of these words as 
possible. Each subsequent learning trial involves the selective presentation of only those 
items that were not recalled on the immediately preceding trial. The SRT distinguishes 
between short-term and long-term components of memory by measuring recall of items 
that were not presented on a given trial. The rate at which subjects learn can also be 
evaluated. Alternate forms reliability among those with Alzheimer’s disease is good 
(.92); however, in other populations is variable (.48-.85). 
 
Visual Memory 
Rey-Osterrieth Complex Figure Test 
The Rey-Osterrieth Complex Figure Test (RCFT) assesses visual-spatial 
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constructional ability and visual memory. It also permits assessment of a variety of 
cognitive processes including planning, organizational skills, and problem solving 
strategies, as well as perceptual, motor, and episodic memory functions. The examinee is 
asked to copy the Rey-Osterrieth figure and is then asked to recall it from memory 3 
minutes and 30 minutes after the copy trial. The internal consistency of the Rey Figure 
was evaluated by treating each detail as an item and computing split-half and alpha 
coefficients (Berry et al., 1991; Fasteneau et al., 1996). Both split-half and coefficient 
alpha reliabilities were greater than .60 for the copy condition and greater than .80 for 
recall conditions in adults, suggesting that all of the details tap into a single factor. Test-
retest reliability for Immediate Recall r = .76, Delayed Recall r = .89 and Recognition 
Total Correct r = .87) in a sample of 12 normal subjects after a retest interval of about 6 
months. However, Berry et al. (1991) retested elderly individuals after 1 year and found 
that the copy condition was not reliable across this interval. Reliabilities of the 
immediate-recall and 30-minute-delay trials were also low (.47 to .59). Others have 
reported somewhat higher reliabilities for this population (Mitrushina and Satz, 1991). 
The RCFT Copy, 3-minute Recall and 30-minute Recall and Recognition Total Correct 
scores were significantly correlated with tasks requiring memory and constructional 
ability (BVRT Total Correct, RAVLT Trial 5, Form Discrimination, Hooper, Trails B, 
and the Token Test). Scores on the RCFT are moderately correlated to performance on 
visual-spatial subtests (Wechsler Intelligence Test’s Block Design and Object Assembly; 
e.g., Poulton & Moffitt, 1995; Tombaugh et al. 1992; Wood et al., 1982). 
 
 
 27 
Executive Functioning  
Trail Making Test B 
The Trail Making Test (TMT) is a measure of attention, speed and mental 
flexibility. The test requires the examinee to connect, by making pencil lines, 25 
encircled numbers and letters in alternating order. The TMT test-retest reliability varies 
with the age range and population studied but is for the most part adequate. In older 
adults 1-year-test-retest reliabilities were sufficient (.67‒.72).  
 
Language 
Semantic Fluency (Animals) 
The Semantic Fluency test evaluates the spontaneous production of words under 
restricted search conditions. The examinee is asked to produce as many animal names as 
possible within a one-minute interval. The test-retest reliability of Semantic Fluency 
when using the category Animals, is high; Bird et al. (2004) found that only 10% of his 
sample (retested 1 month post initial assessment) had a change in score that fell outside 
the reliability coefficient indices.   
 
Boston Naming Test‒2 
 The Boston Naming Test‒2 (BNT‒2) is a visual naming task involving 60 black 
and white drawings of common objects. The BNT‒2 was originally published by Kaplan 
et al. (1978). The stimuli to be named for the BNT‒2 are line drawings of objects with 
increasing difficulty, ranging from simple, high-frequency vocabulary words (e.g., comb) 
to rare words (e.g., abacus). The test-retest reliability over short intervals is high (r = 91; 
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SEM = 1.02). The BNT‒2 correlates highly with other language measures of its kind; 
Visual Naming Test of Multilingual Aphasia Examination (r = .76 to .86, Axelrod et al. 
1994).  
 
IQ 
Wechsler Test of Adult Reading 
The Wechsler Test of Adult Reading (WTAR) is an assessment of premorbid 
functioning in adults. It requires the examinee to read aloud irregularly spelled words. 
The test includes 50 words that become progressively irregular. The WTAR shows 
excellent internal consistency with coefficients ranging from .90 to .97 for the U.S. 
standardization sample. The test-retest reliability tends to be fairly stable over time. 
According to the manual, 319 participants completed the test on two separate occasions, 
spaced 2 to 12 weeks apart with an average interval about 35 days. Test-retest 
correlations were very good (>.90) and practice effects were minimal.  
 
Mood 
Hamilton Depression Rating Scale 
The Hamilton Depression Rating Scale (Ham-D) is designed for adults and is 
used to rate the severity of their depression by probing mood, feelings of guilt, suicide 
ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms. 
The scale contains 17 items pertaining to symptoms of depression experienced over the 
past week. A score of 0-7 is considered to be normal. Scores of 20 or higher indicate 
moderate, severe, or very severe depression. Internal reliability of the Ham-D is 
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estimated to be from 0.46 to 0.97. In terms of inter-rater reliability, Pearson’s r is 
estimated to be from 0.82 to 0.98. Retest reliability is estimated to be from 0.81 to 0.98. 
Established criteria are met for convergent, discriminant, and predictive validity. 
 
Procedures 
After complete description of the study to the subjects, written informed consent 
was obtained in accordance with the UCLA Human Subjects Protection Committee 
procedures. At both their initial and follow-up visits, all subjects underwent diagnostic 
evaluation including physical and medical examination, laboratory screening blood tests 
that ruled out medical conditions possibly affecting cognition, medical history 
assessment, and neuropsychological testing. Subjects were asked to return for follow-up 
at a two-year interval. 
 
Data Analysis and Procedures 
SPSS 17 was used for all analyses for the purposes of using neuropsychological 
and mood assessments within a battery to predict conversion from normal to either MCI 
or AD. The data was first cleaned and screened for missing data eliminating participants 
with missing data of interest. Frequency analyses were conducted for all demographic 
variables of interest in the study. Conversion outcomes were dichotomously coded as 
either converted normal/MCI or AD or normal converted to MCI. Univariate logistic 
regression analysis was used to determine conversion to MCI and AD for all 
neuropsychological tests. Multivariate models were constructed based on significant 
variables after applying the bonferroni correction method to variables in Hypothesis 1.1 
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and 1.3 for each multivariate analysis. In order to correct for error caused by group size 
discrepancy between decliners and non-decliners, a second set of univariate binary 
regressions were conducted utilizing a demographically (gender, age, education and 
ethnicity) matched sub-set of non-decliners.  
 
Statistical Analysis 
Aim 1: To determine what neuropsychological measures best predict conversion 
from normal aging to Mild Cognitive Impairment and Mild Cognitive Impairment to 
probable Alzheimer’s disease two years prior to conversion among older adults. 
 Hypothesis 1.1:  Individually, the Buschke Selective Reminding Test (Total, 
Delay, and Recognition), Rey-Osterrieth Complex Figure Test (Copy, Delay, 
and Retention), Boston Naming Test, Trail Making Test B, and Animals verbal 
fluency test will predict conversion to MCI. To test hypothesis 1.1 individual, 
six univariate logistical regressions were conducted.  
 Hypothesis 1.2: After applying the bonferroni correction method to significant 
predictors from Hypothesis 1.1, a multivariate logistic regression model was 
constructed to predict conversion to MCI. To test hypothesis 1.2, the following 
neuropsychological tests were used within the model, Buschke Total, Buschke 
Delay, RCFT Retention and Trails B. 
 Hypothesis 1.3: Individually, the Buschke Selective Reminding Test (Total, 
Delay, and Recognition), Rey-Osterrieth Complex Figure Test (Copy, Delay, 
and Retention), Boston Naming Test, Trail Making Test B, and Animals verbal 
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fluency test will predict conversion to AD. To test hypothesis 1.1, six univariate 
logistical regressions were conducted. 
 Hypothesis 1.4: After applying the bonferroni correction method to significant 
predictors from 1.3, a multivariate logistic regression model was constructed to 
predict conversion to AD. To test hypothesis 1.3, the following 
neuropsychological tests were used within the model, the Buschke Total, 
Buschke Delay, Buschke Recognition, RCFT Copy and RCFT Delay. 
Aim 2: To determine if depressive symptoms predict conversion to a more severe 
cognitive to disorder (MCI or AD) two years prior to conversion. 
 Hypothesis 2.1: Incidence of depression as measured by the Hamilton 
Depression Scale at time of testing will predict conversion to MCI. To test 
hypothesis 2.1 a univariate logistical regression model was constructed to 
predict conversion of MCI based on depression scores. 
 Hypothesis 2.2: Incidence of depression as measured by the Hamilton 
Depression Scale at time of testing will predict conversion to AD. To test 
hypothesis 2.2 univariate logistical regression model was constructed to predict 
conversion of AD based on depression scores. 
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CHAPTER THREE  
RESULTS 
Sample Characteristics 
Descriptive characteristics of the sample can be found in Table 1.   
 
 
Table 1 
 
Descriptive Characteristics of the Sample (n=130) 
 Total  
n=130 
Convert to MCI  Convert to AD  
No Conversion 
(n=61) 
Conversion to 
MCI (n=15) 
No conversion 
(n=121) 
Conversion to 
AD (n=9) 
Male 59% (n=55) (n=23) 47% (n=7) (n=48) 67% (n=6) 
Female 41% (n=78) (n=38) 53% (n=8) (n=73) 33% (n=3) 
Ethnicity      
                   Latino 3% (n=4) 0% (n=0) 0% (n=0) 3% (n=4) 0% (n=0) 
     Asian American 5% (n=6) 3% (n=2) 0% (n=0) 5% (n=6) 0% (n=0) 
  African American 5% (n=7) 0% (n=0) 0% (n=0) 6% (n=7) 0% (n=0) 
Caucasian 87% (n=116) 97% (n=59) 100% (n=15) 86% (n=104) 100% (n=9) 
Education 16.39 (SD=2.97) 16.67 (2.94) 15.72 (SD=3.24) 16.45 (3.03) 15.78 (SD=2.77) 
Age 61.44 (SD=11.30) 60.84 (1.38) 65.20(SD=11.42) 60.69 (11.15) 68.56 (SD=9.98) 
 
 
 
 
Aim 1 
 The first aim was to determine what neuropsychological measures best predict 
conversion from normal aging to Mild Cognitive Impairment and Mild Cognitive 
Impairment to probable Alzheimer’s disease two years prior to conversion among older 
adults. Correlation analyses were conducted to determine whether there was significant 
shared variance among the measures.  
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Table 2.  
 
Correlations between Neuropsychological Tests 
 
 RCFT 
Copy 
RCFT 
Delay 
RCFT 
Retain 
RCFT 
Recog 
Buschke 
Total 
Buschke 
Delay 
Buschke 
Recog 
Boston Trails B Animals 
Rey Copy 1.00 0.408** 0.256** 0.270** 0.278** 0.246** 0.115 0.409** -0.461** 0.161 
Rey Delay 0.408** 1.00 0.596** 0.60 0.245** 0.218** 0.185** 0.286** 0.258** 0.220* 
Rey Retain 0.256** 0.596** 1.00 0.028 0.385** 0.387** 0.207* 0.299** 0.343** 0.217* 
Rey Recog 0.270** 0.60 0.028 1.00 0.94 0.117 0.002 0.045 0.161 0.144 
Buschke Total 0.278** 0.245** 0.385** 0.94 1.00 0.860** 0.600** 0.239** -0.392** 0.325** 
Buschke Delay 0.246** 0.218** 0.387** 0.117 0.860** 1.00 0.630** 0.159 -0.320** 0.307** 
Buschke Recog 0.115 0.185** 0.207* 0.002 0.600** 0.630** 1.00 0.259** -0.246** 0.270** 
Boston 0.409** 0.286** 0.299** 0.045 0.239** 0.159 0.259** 1.00 -0.479** 0.369** 
Trails B -0.461** 0.258** 0.343** 0.161 - 0.392** -0.320** -0.246** -0.479** 1.00 -0.266** 
Animals 0.161 0.220* 0.217* 0.144 0.325** 0.307** 0.270** 0.369** -0.266** 1.00 
   
 
 
Hypothesis 1.1 
Hypothesis 1.1 was partially supported. The results of the 10 individual univariate 
logistical regressions showed the Buschke Selective Reminding Test (Total & Delay), 
Rey-Osterrieth Complex Figure Test (Retention) and Trail Making Test B individually 
predicted conversion to MCI after applying the bonferroni correction method. Results 
from these tests are found in Table 3. 
 
Table 3.  
 
Univariate Binary Logistic Regression Predicting Conversion from Normal Aging to MCI (61 non convertors, 15 
converted to MCI) 
Variable Wald (df=1) p Odds Ratio (OR) 
RCFT Copy            0.003 .959 1.005 
RCFT Delay                   0.220 .639 0.983 
RCFT Retention 13.663 .000** 0.913 
RCFT Recognition 1.070 .301 3.080 
Buschke Total                - 8.508 .004** 0.944 
Buschke Delay                13.439 .000** 0.645 
Buschke Recognition 5.812 .016 0.256 
Boston 4.518 .034 0.824 
Trails B 9.604 .002** 1.049 
Animals 0.389 .533 0.961 
**Significant at the .005 level (after applying the bonferroni correction method) 
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Hypothesis 1.2 
After applying the bonferroni correction method to significant predictors from 
Hypothesis 1.1, the multivariate logistic regression model showed the Buschke 
Recognition and RCFT Retention as the only significant predictors of conversion to MCI. 
Results from these tests are found in Table 4. Specifically, individuals who were only 
able to retain 30% (SD=2.71) of visual information after a delay (RCFT Retention) were 
more likely to develop MCI at time 2 when compared to individuals who were able to 
retain 54% (SD=3.22) or more of the same visual information. Furthermore, those that 
converted to MCI recognized, on average, approximately 92% of the words they were 
presented with initially, where as those that did not convert, on average, recognized 
approximately 100% of the words. 
 
Table 4.  
 
Multivariate Logistic Regression Predicting Conversion from Normal Aging to MCI (61 non convertors, 15 converted 
normal to MCI) 
Variable Wald (df=1) p Odds Ratio (OR) 
Buschke Total 0.988 .320 1.050 
Buschke Delay 0.774 .379 0.792 
Buschke Recog 4.359    .037** 0.057 
RCFT Retain 8.665    .003** 0.875 
Trails B  0.032 .057 1.062 
**Significant at the .05 level  
 
 
 
 
Hypothesis 1.3 
Hypothesis 1.3 was partially supported. The results of the six individual 
univariate logistical regressions showed the Buschke Selective Reminding Test (Total, 
Delay and Recognition), RCFT (Copy, Delay and Retention) and Trails B predicted 
conversion to AD. Results from these tests are found in Table 5. 
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Table 5.  
 
Univariate Binary Logistic Regression Predicting Conversion from Normal Aging/MCI to Probable Alzheimer’s 
Disease (121 non convertors, 9 converted to probable AD) 
 
Variable Wald (df=1) p Odds Ratio (OR) 
Buschke Total                 12.883 .000** 0.927 
Buschke Delay               - 12.578 .000** 0.550 
Buschke Recognition      12.012 .001** 0.382 
RCFT Copy                    9.786 .002** 0.722 
RCFT Delay                   8.234 .004** 0.780 
RCFT Retention             6.717 .010 0.936 
Boston Naming Test       0.862 .353 0.943 
Trails B  7.142    .008** 1.018 
Animals                           3.171 .075 0.859 
**Significant at the .005 level (after applying the bonferroni correction method) 
 
 
 
 
Hypothesis 1.4 
After applying the bonferroni correction method to significant predictors from 
hypothesis 1.3, the multivariate logistic regression model showed the Buschke Delay as 
the only predictor of conversion to AD. Results from these tests are found in Table 6.  
Specifically, individuals who were not demented at time one but recalled only 
approximately 2 out of 12 words from a list (Buschke Delay=1.89, SD=2.71) were more 
likely to develop dementia by time 2 when compared to individuals who were able to 
recall approximately 8 out of 12 words on this same task (Buschke Delay=8.40, 
SD=3.22). 
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Table 6.  
 
Multivariate Logistic Regression Predicting Conversion from Normal Aging/MCI to Probable Alzheimer’s Disease 
(121 non convertors, 9 converted to probable AD) 
 
Variable Wald (df=1) p Odds Ratio (OR) 
Buschke Total                 0.662 0.416 1.037 
Buschke Delay                  5.689    0.017** 0.537 
Buschke Recognition      0.331 0.565 0.765 
RCFT Copy                       2.931 0.087 0.781 
RCFT Delay                      0.480 0.488 0,924 
**Significant at the .05 level 
 
To correct for error caused by group size discrepancy between converters and 
non-converters, a second set of univariate binary regressions were conducted utilizing a 
demographically (gender, age, education and ethinicity) matched sub-set of non-
converters. The demographic characteristics of these groups are found in Tables 6 and 7.  
 
Table 7. 
 
Comparison demographic data from demographically matched non-converters and converters to MCI 
 Non-converters (N=15) Converted to MCI(N=15) 
Male N=7 N=7 
Female N=8 N=8 
Ethnicity   
           Asian American N=1 N=0 
                   Caucasian N=14 N=15 
Education 15.53 (SD=2.774) 15.73 (SD=3.240) 
Age 64.33 (SD=10.118) 65.20 (SD=11.416) 
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Table 8. 
 
Comparison demographic data from demographically matched non-converters and converters to AD 
 Non-converters (N=(9) Converted to AD (9) 
Male N=5 N=6 
Female N=4 N=3 
Ethnicity   
           Asian American N=1 N=0 
         African American N=2 N=0 
                   Caucasian N=7 N=9 
Education 16.67 (SD=4.664) 15.78 (SD=2.774) 
Age 67.67 (10.087) 68.56 (SD=9.976) 
 
 
These tests showed that the RCFT Retention was a significant predictor of 
conversion to MCI. Specifically, individuals who were only able to retain 31% 
(SD=15.8) of visual information after a delay (RCFT Retention) were more likely to 
develop MCI at time 2 when compared to individuals who were able to retain 51% 
(SD=21.2) or more of the same visual information. Furthermore, the results revealed that 
the Buschke Delay and the RCFT Retention were significant predictors of conversion to 
AD. Specifically, individuals who were not demented at time one but only retained 30% 
(SD=14.3) of visual information after a delay (RCFT Retention) were more likely to 
develop dementia at time 2 when compared to individuals who were able to retain 51% 
(SD=17.3) or more of the same visual information. Furthermore, those individuals who 
were not demented at time one but recalled only approximately 2 out of 12 words from a 
list (Buschke Delay=2.0, SD=2.7) were more likely to develop dementia by time 2 when 
compared to individuals who were able to recall approximately 7 out of 12 words on this 
same task (Buschke Delay=7.0, SD=4.1). Results of these analyses may be found in 
Table 8 and 9. 
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Table 9.  
 
Univariate Binary Logistic Regression Predicting Conversion from Normal Aging to MCI (15 non convertors, 15 
converted to MCI) 
 
Variable Wald (df=1) p Odds Ratio (OR) 
Total Buschke  0.421 .516 0.988 
Delay Buschke 1.839 .175 0.864 
Recog Buschke 0.393 .531 0.815 
Copy RCFT  0.617 .432 1.085 
Delay Rey-O 0.001 .980 0.999 
Retain Rey-O 5.520    .019** 0.940 
Recog RCFT  0.357 .550 2.154 
Boston  0.200 .655 1.030 
Trails B  0.355 .551 1.046 
Animals 0.355 .551 1.046 
**Significant at the .05 level 
          
 
 
Table 10.  
 
Univariate Binary Logistic Regression Predicting Conversion from normal/MCI to AD (9 non convertors, 9 converted 
to AD) 
 
Variable Wald (df=1) p Odds Ratio 
Total Buschke  3.267 .071 .944 
Delay Buschke  4.910    .027** .675 
Recog Buschke  1.932 .165 .534 
Copy RCFT  3.392 .066 .767 
Delay Rey-O 3.603 .058 .755 
Retain RCFT      3.897    .048** .899 
Recog RCFT                      0.233 .630 .625 
Boston  0.097 .755 .976 
Trails B  0.889 .346 1.010 
Animals  0.986 .321 .903 
**Significant at the .05 level 
 
 
 
 
Aim 2 
The second aim was to determine whether depressive symptoms predict 
conversion to a more severe cognitive disorder (MCI or AD) two years prior to 
conversion. 
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Hypothesis 2.1 
Hypothesis 2.1 was not supported. The results of the univariate binary logistical 
regression model indicated that depression scores from the Hamilton Depression Scale 
did not significantly predict conversion to MCI. Results of this analysis are found in table 
10. 
 
Table 11.  
 
Univariate Binary Logistic Regression Predicting Conversion from Normal Aging to MCI (61 non convertors, 15 
converted normal to MCI) 
 
Variable Wald (df=1) p Odds Ratio 
Hamilton Depression .055 .815 1.024 
 
 
Hypothesis 2.2 
Hypothesis 2.2 was not supported. The results of the univariate binary logistical 
regression model indicated that depression scores from the Hamilton Depression Scale do 
not significantly predict conversion to AD. Results from these tests are found in Table 11. 
 
Table 12.  
 
Univariate Binary Logistic Regression Predicting Conversion from Normal Aging/MCI to Probable Alzheimer’s 
Disease (121 non convertors, 9 converted to probable AD) 
Variable Wald (df=1) p  Odds Ratio 
Hamilton Depression .129 .719  1.042 
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CHAPTER FOUR 
DISCUSSION 
Purpose of the Study 
The current study sought to establish which neuropsychological measures best 
predict future cognitive decline. More specifically, the purpose of this study was to 
determine the ability of the Buschke Selective Reminding Test, Rey Osterrieth Complex 
Figure Test, Trail Making Test B, semantic fluency (i.e. Animals), the Boston Naming 
Test and their associated cognitive domains (verbal memory, visuospatial memory, 
executive functioning, and language), to predict conversion to a more severe cognitive 
status (e.g., normal aging to MCI, MCI to probable Alzheimer’s disease).  
 
Findings 
The current study revealed that two measures served as predictive indicators of 
conversion to a more severe cognitive status (e.g., MCI, AD). More specifically, the Rey 
Osterrieth Complex Figure Test’s (RCFT) retention score and the Buschke Selective 
Reminding Test’s delayed recall score and recognition score were sensitive in predicting 
conversion to MCI and dementia of the Alzheimer’s type. When assessing the entire 
study sample, the RCFT retention score predicted conversion from normal aging to MCI. 
Those who converted to MCI on average retained approximately 30% of what they 
initially encoded from the complex figure, while those who remained stable recalled 
roughly 54%. Furthermore, those that converted to MCI recognized, on average, 
approximately 92% of the 12 words they were presented with initially, where as those 
that did not convert, on average, recognized approximately 100% of the words. The 
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Buschke SRT delayed recall score predicted conversion from normal aging or MCI to 
dementia of the Alzheimer’s type. Those who converted to dementia of the Alzheimer’s 
type accurately recalled approximately two of twelve words while participants that 
remained stable accurately recalled approximately eight out of twelve words. When 
examining the demographically matched subsample, conversion to MCI was predicted by 
the RCFT and conversion to dementia of the Alzheimer’s type was predicted by both the 
RCFT and the Buschke SRT.  
It is not surprising that tests of visual and verbal memory were sensitive in 
predicting conversion as the literature supports this finding. As mentioned previously, 
memory of lists of words such as the California Verbal Learning Test (Albert et al., 2001; 
Beck et al., 2012; Rabin et al., 2009; Silva et al., 2012), Auditory Verbal Learning Test 
(Landau et al., 2010), Rey Auditory Verbal Learning Test (Tierney et al., 2005), 
Neurological Assessment Battery List Learning Test (Gavett et al., 2010), and the 
Buschke Selective Reminding Test (Devanand et al., 2008; Grober et al., 2008; Masur et 
al., 1994; Tabert et al., 2006) have all been shown to be predictive of conversion to a 
more severe memory disorder. Similarly, researchers have identified word pair tests such 
as the Semantic Object Retrieval Test (Kraut et al., 2007) and Wechsler Memory Scale’s 
Verbal Paired Associates (Venneri et al., 2011) as accurate identifiers of those who will 
convert. Furthermore, research has found lower scores on tests of verbal memory of short 
stories, such as the Wechsler Memory Scale’s Logical Memory (Rabin et al., 2009), to be 
predictive of conversion.  Researchers have also identified tests of verbal long-term 
memory, such as the Wechsler’s Adult Intelligence Scale’s Information (Tierney et al., 
2005) and tests of cued verbal memory, such as the RI-48 Test (Hanseeuw & Ivanoiu, 
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2011) to be adequate in predicting who will convert. With regards to visual memory, 
researchers have found tests such as the immediate recall of the figures from Wechsler 
Memory Scales (Albert et al., 2001) and the Rey-Osterrieth Complex Figure Test (Alladi 
et al., 2006; Borroni et al., 2006; Guo et al., 2009) to predict conversion to a more severe 
cognitive diagnosis. 
Additionally, research suggests that tau protein tangles and amyloid plaques 
spread in a predictable, nonrandom manner beginning in the entorhinal region (“relay 
station” between the hippocampus and neocortex), spreading to the hippocampus 
(memory center) and neocortex (responsible for higher functions such as sensory 
perception, conscious thought and language; Braak & Braak, 1991). The entorhinal-
hippocampus system plays an important role in autobiographical, declarative and 
episodic memories and in particular spatial memories including memory formation, 
memory consolidation, and memory optimization in sleep. Because this entorhinal region 
is one of the first areas impacted by tau tangles—accumulating and eventually causing 
neuronal death—it is expected that the tests measuring functions of this region would 
predict conversion before tests measuring functions of domains impacted later in the 
disease process (e.g., language, executive functioning). Braak and Braak found that 
during the stage in which neuronal death has begun in the entorhinal region, cognitive 
testing would show minimal impairment, suggesting that such tests would likely need to 
be highly sensitive. However, the literature is abundant in suggesting that measures in 
other domains (e.g., language, executive functioning) are also sensitive in predicting 
conversion to a more severe memory disorder (e.g., Albert et al., 2001; Balota et al., 
2010; Bennett et al., 2002; Chen et al., 2000; Dickerson, Sperling, Hyman, Albert, & 
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Blacker, 2007; Ewers et al., 2012; Jacobs et al., 1995; Kraut et al., 2007; Kurt, Yener, & 
Oguz, 2011; Lonie et al., 2009; Tabert et al., 2006; Zhou, Nakatani, Teramukai, Nagai, & 
Fukushima, 2012).  This finding was not upheld in the present study.  
 There are several reasons why these findings may be lacking in the present study. 
For instance, the present study implemented rigorous diagnostic methods when 
determining conversion status including multiple sources of diagnosis (e.g., PET scan, 
clinical consensus by neurology, geriatric psychiatry, neuropsychology, and radiology), 
utilization of neuropsychological tests from each cognitive domain, and in some cases, 
multiple tests within a domain, and stringent statistical processes were used (examined 
the impact of age, education, and gender on conversion and utilized statistical corrections 
when running multiple tests). Other studies have utilized extensive diagnostic methods 
when assessing for conversion, including imaging (Artero, Tierney, Touchon, & Ritchie, 
2003; Bennett et al., 2002; Borroni et al., 2006; Chen et al., 2000; Estevez-Gonzalez, 
Kulisevsky, Boltes, Otermin, & Garcia-Sanchez, 2003; Grober et al., 2008; Grober et al., 
2000; Perri, Serra, Carlesimo, & Caltagirone, 2007; Rami et al., 2007); however, the 
majority of studies have not examined the measures of interest, namely the Buschke 
Selective Reminding Test, Boston Naming Test and the Rey Osterrieth Complex Figure 
Test. Few studies have been found that were similar to the current study’s diagnostic 
rigor and assessment measures used (Devanand et al., 2008; D. M. Jacobs et al., 1995; 
Tabert et al., 2006). However, the participants within the Jacobs et al. study did not 
undergo imaging as way of confirming conversion. The Tabert et al. study included 
imaging as part of their conversion determination, but did not include the Rey Osterrieth 
Complex Figure Test within their neuropsychological battery.    
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Limitations 
A major caveat to the current study is a relatively small sample size. Small sample 
size limits statistical power and may decrease the likelihood of detecting significant 
predictors of conversion. Other similar studies with larger sample sizes have found 
somewhat differing findings. For instance, Jacobs et al. (1995) in a community based 
sample of approximately 443 people, found that in addition to the immediate recall on the 
selective reminding test, the Boston Naming Test and the WAIS-III Similarities were 
predictive of conversion to dementia. Additionally, Chen et al. (2000), in a large sample 
of approximately 600 individuals, found word list delayed recall and the Trail-making 
Test B to predict conversion to dementia.  
Another limitation of the study is sample diversity, both with regards to ethnicity 
and education. The current study’s sample consists of mainly Caucasian, college 
educated individuals and thus has limited generalizability. It is important to consider that 
individuals of diverse demographics may differ with regards to cognitive degeneration 
(e.g., higher education may buffer against a cognitive degenerative disease diagnosis) and 
thus varying assessment measures may be a better fit to detect progression among these 
individuals.  
 
Implications 
The findings of the current study suggest two neuropsychological measures seem 
to be good at predicting conversion to a more severe cognitive status among a primarily 
Caucasian, college educated sample. Generalization of these findings is cautioned; 
however, once similar results are found among replications of this study with diverse 
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samples, it may be that neuropsychologists use such measures to determine whether a 
patient may later convert to a more severe memory disorder with the goal of intervening 
to delay progression (Blasko et al., 2012; Cheng et al., 2013; Lee et al., 2013; Miller et 
al., 2012; Roberts et al., 2008; Roberts et al., 2012; Wenisch et al., 2007). Furthermore, it 
is critical that those who develop Alzheimer’s disease are studied at the earliest stages in 
order to better understand the progression, thus facilitating the development of 
increasingly advanced treatments.  
It is important to highlight that although it is essential to determine whether an 
individual will convert to a more severe cognitive diagnosis, it is also imperative to 
recognize that the job of the provider is not simply to inform our patient of their 
likelihood of converting. Rather, our goal is to help inform the patient of their cognitive 
strengths and weaknesses as it relates to their daily functioning in order to inform coping 
strategies as well as intervene via cognitive training, diet, exercise, etc. Therefore, while 
the findings of this study serve an important role in informing later decline in cognitive 
status, it is not suggested that these tests be used in separation of a full 
neuropsychological battery, particularly when a decline in patient functioning is reported. 
As doing so may inhibit the provider from gathering measurable cognitive strengths and 
weaknesses from each cognitive domain and more importantly, offering relevant coping 
strategies and recommendations related to these findings.  
 
Conclusion 
In sum, the current study sought to determine which neuropsychological measures 
best predict future cognitive decline. Among the current study’s sample, the Buschke 
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Selective Reminding Test and the Rey Osterrieth Complex Figure Test are sensitive in 
predicting conversion to a more severe cognitive disorder (e.g., MCI, probable AD) two 
years prior to conversion. These findings are in line with the majority of past research 
that demonstrates verbal and visual memory tasks to be the most predictive of 
conversion. However, other studies have generated some conflicting results 
demonstrating tests of executive functioning and language as predictors of conversion; 
these studies are fewer. The current study’s investigators examined the Buschke SRT and 
Rey Osterrieth Complex Figure Test (among others: BNT, TMT B, Animals) due to the 
unique capability of these tests to measure multiple cognitive resources (e.g., Buschke 
SRT: verbal memory, working memory, executive functioning; RCFT: visual memory, 
executive functioning). This is the only identified study that has examined these measures 
together and implemented rigorous diagnostic means to determine conversion (e.g., 
clinical consensus, imaging, full neuropsychological battery).  These findings may serve 
to assist both clinicians and researchers in detecting individuals who may convert to 
either MCI or probable AD. Future studies may seek to carry out the current 
methodology among more diverse samples in order to determine the sensitivity of the 
current study’s measures among individuals of various demographics.  
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